Migraine: integrated approaches to clinical management and emerging treatments

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Migraine : integrated approaches to clinical management and emerging treatments. / Ashina, Messoud; Buse, Dawn C.; Ashina, Håkan; Pozo-Rosich, Patricia; Peres, Mario F.P.; Lee, Mi Ji; Terwindt, Gisela M.; Halker Singh, Rashmi; Tassorelli, Cristina; Do, Thien Phu; Mitsikostas, Dimos D.; Dodick, David W.

I: Lancet, Bind 397, Nr. 10283, 17.04.2021, s. 1505-1518.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Ashina, M, Buse, DC, Ashina, H, Pozo-Rosich, P, Peres, MFP, Lee, MJ, Terwindt, GM, Halker Singh, R, Tassorelli, C, Do, TP, Mitsikostas, DD & Dodick, DW 2021, 'Migraine: integrated approaches to clinical management and emerging treatments', Lancet, bind 397, nr. 10283, s. 1505-1518. https://doi.org/10.1016/S0140-6736(20)32342-4

APA

Ashina, M., Buse, D. C., Ashina, H., Pozo-Rosich, P., Peres, M. F. P., Lee, M. J., Terwindt, G. M., Halker Singh, R., Tassorelli, C., Do, T. P., Mitsikostas, D. D., & Dodick, D. W. (2021). Migraine: integrated approaches to clinical management and emerging treatments. Lancet, 397(10283), 1505-1518. https://doi.org/10.1016/S0140-6736(20)32342-4

Vancouver

Ashina M, Buse DC, Ashina H, Pozo-Rosich P, Peres MFP, Lee MJ o.a. Migraine: integrated approaches to clinical management and emerging treatments. Lancet. 2021 apr. 17;397(10283):1505-1518. https://doi.org/10.1016/S0140-6736(20)32342-4

Author

Ashina, Messoud ; Buse, Dawn C. ; Ashina, Håkan ; Pozo-Rosich, Patricia ; Peres, Mario F.P. ; Lee, Mi Ji ; Terwindt, Gisela M. ; Halker Singh, Rashmi ; Tassorelli, Cristina ; Do, Thien Phu ; Mitsikostas, Dimos D. ; Dodick, David W. / Migraine : integrated approaches to clinical management and emerging treatments. I: Lancet. 2021 ; Bind 397, Nr. 10283. s. 1505-1518.

Bibtex

@article{9dc6a6257f98458fa73703c235015c4f,
title = "Migraine: integrated approaches to clinical management and emerging treatments",
abstract = "Migraine is a highly disabling neurological disorder that directly affects more than 1 billion individuals worldwide. Available treatment options differ between countries and include acute, preventive, and non-pharmacological therapies. Because of major progress in the understanding of migraine pathogenesis, novel mechanism-based medications have emerged and expanded the armamentarium of treatments. We provide a comprehensive overview of the current standard of care that will enable informed clinical management. First, we discuss the efficacy, tolerability, and safety profile of various pharmacological therapies for acute and preventive treatment of migraine. Second, we review the current knowledge on non-pharmacological therapies, such as neuromodulation and biobehavioural approaches, which can be used for a multidisciplinary approach to clinical management. Third, we emphasise that any effective treatment strategy starts with building a therapeutic plan tailored to individual clinical characteristics, preferences, and needs. Finally, we explore the outlook of emerging mechanism-based treatments that could address unmet challenges in clinical management of migraine.",
author = "Messoud Ashina and Buse, {Dawn C.} and H{\aa}kan Ashina and Patricia Pozo-Rosich and Peres, {Mario F.P.} and Lee, {Mi Ji} and Terwindt, {Gisela M.} and {Halker Singh}, Rashmi and Cristina Tassorelli and Do, {Thien Phu} and Mitsikostas, {Dimos D.} and Dodick, {David W.}",
year = "2021",
month = apr,
day = "17",
doi = "10.1016/S0140-6736(20)32342-4",
language = "English",
volume = "397",
pages = "1505--1518",
journal = "The Lancet",
issn = "0140-6736",
publisher = "TheLancet Publishing Group",
number = "10283",

}

RIS

TY - JOUR

T1 - Migraine

T2 - integrated approaches to clinical management and emerging treatments

AU - Ashina, Messoud

AU - Buse, Dawn C.

AU - Ashina, Håkan

AU - Pozo-Rosich, Patricia

AU - Peres, Mario F.P.

AU - Lee, Mi Ji

AU - Terwindt, Gisela M.

AU - Halker Singh, Rashmi

AU - Tassorelli, Cristina

AU - Do, Thien Phu

AU - Mitsikostas, Dimos D.

AU - Dodick, David W.

PY - 2021/4/17

Y1 - 2021/4/17

N2 - Migraine is a highly disabling neurological disorder that directly affects more than 1 billion individuals worldwide. Available treatment options differ between countries and include acute, preventive, and non-pharmacological therapies. Because of major progress in the understanding of migraine pathogenesis, novel mechanism-based medications have emerged and expanded the armamentarium of treatments. We provide a comprehensive overview of the current standard of care that will enable informed clinical management. First, we discuss the efficacy, tolerability, and safety profile of various pharmacological therapies for acute and preventive treatment of migraine. Second, we review the current knowledge on non-pharmacological therapies, such as neuromodulation and biobehavioural approaches, which can be used for a multidisciplinary approach to clinical management. Third, we emphasise that any effective treatment strategy starts with building a therapeutic plan tailored to individual clinical characteristics, preferences, and needs. Finally, we explore the outlook of emerging mechanism-based treatments that could address unmet challenges in clinical management of migraine.

AB - Migraine is a highly disabling neurological disorder that directly affects more than 1 billion individuals worldwide. Available treatment options differ between countries and include acute, preventive, and non-pharmacological therapies. Because of major progress in the understanding of migraine pathogenesis, novel mechanism-based medications have emerged and expanded the armamentarium of treatments. We provide a comprehensive overview of the current standard of care that will enable informed clinical management. First, we discuss the efficacy, tolerability, and safety profile of various pharmacological therapies for acute and preventive treatment of migraine. Second, we review the current knowledge on non-pharmacological therapies, such as neuromodulation and biobehavioural approaches, which can be used for a multidisciplinary approach to clinical management. Third, we emphasise that any effective treatment strategy starts with building a therapeutic plan tailored to individual clinical characteristics, preferences, and needs. Finally, we explore the outlook of emerging mechanism-based treatments that could address unmet challenges in clinical management of migraine.

U2 - 10.1016/S0140-6736(20)32342-4

DO - 10.1016/S0140-6736(20)32342-4

M3 - Review

C2 - 33773612

AN - SCOPUS:85103990856

VL - 397

SP - 1505

EP - 1518

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 10283

ER -

ID: 261515711